Cargando…

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice

BACKGROUND: Huntington's disease (HD) is a hereditary neurodegenerative disorder caused by a CAG repeat expansion in the HD gene. The huntingtin protein expressed from HD has an unknown function but is suggested to interact with proteins involved in the cell division machinery. The R6/2 transge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersén, Åsa, Stewénius, Ylva, Björkqvist, Maria, Gisselsson, David
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236918/ https://www.ncbi.nlm.nih.gov/pubmed/16159402 http://dx.doi.org/10.1186/1471-2121-6-34

Ejemplares similares

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
por: Dickson, Elna, et al.
Publicado: (2022)

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice
por: Soylu-Kucharz, Rana, et al.
Publicado: (2017)

Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
por: Gil, Joana MAC, et al.
Publicado: (2004)

Binomial Mitotic Segregation of MYCN-Carrying Double Minutes in Neuroblastoma Illustrates the Role of Randomness in Oncogene Amplification
por: Lundberg, Gisela, et al.
Publicado: (2008)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
por: Dickson, Elna, et al.
Publicado: (2022)

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease
por: McCourt, Andrew C., et al.
Publicado: (2016)

Somatic PMK-1/p38 signaling links environmental stress to germ cell apoptosis and heritable euploidy
por: Soltanmohammadi, Najmeh, et al.
Publicado: (2022)

iNKT Cell Activation Exacerbates the Development of Huntington's Disease in R6/2 Transgenic Mice
por: Park, Hyun Jung, et al.
Publicado: (2019)

Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
por: Sjögren, Marie, et al.
Publicado: (2017)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

Can trophectoderm morphology act as a predictor for euploidy?
por: Yoshida, Ivan H, et al.
Publicado: (2018)

The Frequency of Chromosomal Euploidy Among 3PN Embryos
por: Mutia, Kresna, et al.
Publicado: (2019)

Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
por: Stan, Tiberiu Loredan, et al.
Publicado: (2020)

When the Genome Plays Dice: Circumvention of the Spindle Assembly Checkpoint and Near-Random Chromosome Segregation in Multipolar Cancer Cell Mitoses
por: Gisselsson, David, et al.
Publicado: (2008)

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease
por: Duarte, Ana I., et al.
Publicado: (2018)

Author Correction: Somatic PMK-1/p38 signaling links environmental stress to germ cell apoptosis and heritable euploidy
por: Soltanmohammadi, Najmeh, et al.
Publicado: (2023)

Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice
por: Lee, Sung Won, et al.
Publicado: (2018)

Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice
por: Di Pardo, A., et al.
Publicado: (2017)

Stoichiometry of Base Excision Repair Proteins Correlates with Increased Somatic CAG Instability in Striatum over Cerebellum in Huntington's Disease Transgenic Mice
por: Goula, Agathi-Vassiliki, et al.
Publicado: (2009)

A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018)

Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
por: Zhu, S, et al.
Publicado: (2011)

Dysfunctional mitochondrial respiration in the striatum of the Huntington’s disease transgenic R6/2 mouse model
por: Aidt, Frederik Heurlin, et al.
Publicado: (2013)

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
por: Comella Bolla, Andrea, et al.
Publicado: (2019)

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
por: Björkqvist, Maria
Publicado: (2023)

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

Relationship Between Morphology, Euploidy and Implantation Potential of Cleavage and Blastocyst Stage Embryos
por: Majumdar, Gaurav, et al.
Publicado: (2017)

Oocytes With Smooth Endoplasmic Reticulum Aggregates May Not Impact Blastocyst Euploidy Rate
por: Xu, Jian, et al.
Publicado: (2022)

IKKβ slows Huntington’s disease progression in R6/1 mice
por: Ochaba, Joseph, et al.
Publicado: (2019)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

Erratum: Relationship between morphology, euploidy and implantation potential of cleavage and blastocyst stage embryos
Publicado: (2017)

Development of an artificial intelligence based model for predicting the euploidy of blastocysts in PGT-A treatments
por: Yuan, Zhenya, et al.
Publicado: (2023)

Does dual trigger improve euploidy rate in normoresponder? A cross-sectional study
por: Yildirim Kopuk, Sule, et al.
Publicado: (2023)

The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease
por: Bett, John S., et al.
Publicado: (2009)

Continuous and Periodic Expansion of CAG Repeats in Huntington's Disease R6/1 Mice
por: Møllersen, Linda, et al.
Publicado: (2010)

Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease
por: de Paula Nascimento-Castro, Cristine, et al.
Publicado: (2018)

Day 7 blastocyst euploidy supports routine implementation for cycles using preimplantation genetic testing
por: Whitney, John B., et al.
Publicado: (2019)

Stag3 regulates microtubule stability to maintain euploidy during mouse oocyte meiotic maturation
por: Zhang, Mianqun, et al.
Publicado: (2016)

Relationship Between Number of Oocytes Retrieved and Embryo Euploidy Rate in Controlled Ovarian Stimulation Cycles
por: Buerger, Jonathan D., et al.
Publicado: (2022)

The Role of Hypothalamic Pathology for Non-Motor Features of Huntington’s Disease
por: Cheong, Rachel Y., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qgpqdni77m5t8midvs082tu287